v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (loss)
Beginning balance (in shares) at Jan. 31, 2025 146,360,207        
Beginning balance at Jan. 31, 2025 $ 1,301,121        
Ending balance (in shares) at Apr. 30, 2025 146,360,207        
Ending balance at Apr. 30, 2025 $ 1,301,121        
Beginning balance (in shares) at Jan. 31, 2025   45,782,871      
Beginning balance at Jan. 31, 2025 (1,186,899) $ 1 $ 467,835 $ (1,617,113) $ (37,622)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (61,257)     (61,257)  
Other comprehensive (loss) income, net of tax 26,035       26,035
Issuance of equity-classified warrants in connection with term loan 11,007   11,007    
Issuance of common stock upon exercise of stock options (in shares)   187,013      
Issuance of common stock upon exercise of stock options 1,820   1,820    
Vesting of early exercised stock options 287   287    
Stock-based compensation 17,830   17,830    
Ending balance (in shares) at Apr. 30, 2025   45,969,884      
Ending balance at Apr. 30, 2025 $ (1,191,177) $ 1 498,779 (1,678,370) (11,587)
Beginning balance (in shares) at Jan. 31, 2025 146,360,207        
Beginning balance at Jan. 31, 2025 $ 1,301,121        
Ending balance (in shares) at Jul. 31, 2025 146,360,207        
Ending balance at Jul. 31, 2025 $ 1,301,121        
Beginning balance (in shares) at Jan. 31, 2025   45,782,871      
Beginning balance at Jan. 31, 2025 (1,186,899) $ 1 467,835 (1,617,113) (37,622)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (99,880)        
Ending balance (in shares) at Jul. 31, 2025   46,331,272      
Ending balance at Jul. 31, 2025 $ (1,208,451) $ 1 522,555 (1,716,993) (14,014)
Beginning balance (in shares) at Apr. 30, 2025 146,360,207        
Beginning balance at Apr. 30, 2025 $ 1,301,121        
Ending balance (in shares) at Jul. 31, 2025 146,360,207        
Ending balance at Jul. 31, 2025 $ 1,301,121        
Beginning balance (in shares) at Apr. 30, 2025   45,969,884      
Beginning balance at Apr. 30, 2025 (1,191,177) $ 1 498,779 (1,678,370) (11,587)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (38,623)     (38,623)  
Other comprehensive (loss) income, net of tax (2,427)       (2,427)
Issuance of common stock upon exercise of stock options (in shares)   361,388      
Issuance of common stock upon exercise of stock options 4,006   4,006    
Vesting of early exercised stock options 296   296    
Stock-based compensation 19,474   19,474    
Ending balance (in shares) at Jul. 31, 2025   46,331,272      
Ending balance at Jul. 31, 2025 $ (1,208,451) $ 1 522,555 (1,716,993) (14,014)
Beginning balance (in shares) at Jan. 31, 2026 0        
Beginning balance at Jan. 31, 2026 $ 0        
Ending balance (in shares) at Apr. 30, 2026 0        
Ending balance at Apr. 30, 2026 $ 0        
Beginning balance (in shares) at Jan. 31, 2026 [1]   249,174,777      
Beginning balance at Jan. 31, 2026 1,208,061 $ 2 [1] 3,226,427 (2,015,143) (3,225)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (20,506)     (20,506)  
Other comprehensive (loss) income, net of tax (5,632)       (5,632)
Issuance of common stock upon exercise of stock options (in shares) [1]   2,451,289      
Issuance of common stock upon exercise of stock options 16,269   16,269    
Issuance of common stock upon settlement of restricted stock units (in shares) [1]   945,347      
Issuance of common stock upon settlement of restricted stock units 0        
Vesting of early exercised stock options 38   38    
Stock-based compensation 38,386   38,386    
Ending balance (in shares) at Apr. 30, 2026 [1]   252,571,413      
Ending balance at Apr. 30, 2026 $ 1,236,616 $ 2 [1] 3,281,120 (2,035,649) (8,857)
Beginning balance (in shares) at Jan. 31, 2026 0        
Beginning balance at Jan. 31, 2026 $ 0        
Ending balance (in shares) at Jul. 31, 2026 0        
Ending balance at Jul. 31, 2026 $ 0        
Beginning balance (in shares) at Jan. 31, 2026 [1]   249,174,777      
Beginning balance at Jan. 31, 2026 1,208,061 $ 2 [1] 3,226,427 (2,015,143) (3,225)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (49,623)        
Issuance of common stock upon exercise of stock options (in shares) 7,804,467        
Ending balance (in shares) at Jul. 31, 2026 [1]   259,897,822      
Ending balance at Jul. 31, 2026 $ 1,315,661 $ 2 [1] 3,390,753 (2,064,766) (10,328)
Beginning balance (in shares) at Apr. 30, 2026 0        
Beginning balance at Apr. 30, 2026 $ 0        
Ending balance (in shares) at Jul. 31, 2026 0        
Ending balance at Jul. 31, 2026 $ 0        
Beginning balance (in shares) at Apr. 30, 2026 [1]   252,571,413      
Beginning balance at Apr. 30, 2026 1,236,616 $ 2 [1] 3,281,120 (2,035,649) (8,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (29,117)     (29,117)  
Other comprehensive (loss) income, net of tax (1,471)       (1,471)
Issuance of common stock upon exercise of stock options (in shares) [1]   5,353,178      
Issuance of common stock upon exercise of stock options 61,471   61,471    
Issuance of common stock upon settlement of restricted stock units (in shares) [1]   1,694,883      
Issuance of common stock upon settlement of restricted stock units 0        
Issuance of common stock under employee stock purchase plan (in shares) [1]   278,348      
Issuance of common stock under employee stock purchase plan 4,757   4,757    
Vesting of early exercised stock options 31   31    
Stock-based compensation 43,374   43,374    
Ending balance (in shares) at Jul. 31, 2026 [1]   259,897,822      
Ending balance at Jul. 31, 2026 $ 1,315,661 $ 2 [1] $ 3,390,753 $ (2,064,766) $ (10,328)
[1] The share amounts listed above combine common stock, Class A common stock and Class B common stock. In connection with the completion of our initial public offering, all previously outstanding shares of common stock were reclassified into Class A common stock and Class B common stock. Refer to Note 8 — Stockholders’ Equity for more information.